Development of an ALS Treatment Using Ropinirole Hydrochloride
A project to prepare for a Phase III trial of an ALS treatment using ropinirole hydrochloride, under a license agreement with Alfresa Pharma for development rights and manufacturing and marketing rights.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.